Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Krzysztof Palczewski
Case Western Reserve University, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Polgenix
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Novel therapies to inhibit diabetic retinopathy
Diabetic retinopathy (DR) is a leading cause of vision loss in working-age adults of industrialized nations. Good glycemic control can inhibit DR in motivated patients, but is difficult or impossible for many to achieve and maintain. Likewise, other therapies (such as fibrates) seem to inhibit DR progression, but only in a subgroup of diabetic individuals. Thus, additional therapeutic approaches are needed to reduce vision loss in diabetes. The goal of this application is to identify novel, effective, and safe therapeutics that slow or halt the development and progression of DR in animal models as a prelude to clinical studies.
Filed on May 22, 2015.
Tell us what you know about Krzysztof Palczewski's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Krzysztof Palczewski”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | $80,000 - $99,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.